Usage of Baclofen for Sleep Improvement After Cardiac Surgery

NCT02529514 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-05-13

No results posted yet for this study

Summary

Baclo-Sleep trial aims to investigate the effect of baclofen on sleep after scheduled cardiac surgery.

Conditions

  • Sleep

Interventions

DRUG

Baclofen

25 mg for 7 days at 10 pm every day

DRUG

Placebo

Placebo for 7 days at 10 pm every day

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Pierre Damas, Professor · Soins intensifs généraux

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02529514 on ClinicalTrials.gov